Portable device for monitoring water balance in elderly
便携式老年人水平衡监测装置
基本信息
- 批准号:8591530
- 负责人:
- 金额:$ 52.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-08-01 至 2015-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdultAdverse effectsAffectAgingAnimalsAssisted Living FacilitiesBindingBloodBlood PressureBody WaterBody Weight ChangesCaregiversClinicalClinical ResearchDataDehydrationDementiaDetectionDevicesDiagnosticDizzinessDocumentationElasticityElderlyEngineeringEquilibriumFemaleFluid BalanceGoalsGrantHeadacheHealthcareHome environmentHospitalsHourHumanHydration statusIndividualLaboratoriesLeftLegal patentLifeLightheadednessLiquid substanceLongitudinal StudiesMagnetic Resonance ImagingMarketingMeasurementMeasuresMethodsMonitorMorbidity - disease rateMuscleNauseaNursing HomesOsmolalitiesOutputPatientsPersonsPharmaceutical PreparationsPhasePhysical ExaminationPhysiologic pulsePhysiological ProcessesPlasmaPopulationProductionRegulationRehydrationsReproducibilityResearch DesignRiskSamplingSigns and SymptomsSiteSkinSmall Business Innovation Research GrantSpecific GravitySpeedStagingSweatSystemTechnologyTest ResultTestingThirstTimeTimeLineTissuesTrainingUltrasonicsUltrasonographyUrineValidationValidity and ReliabilityVariantWaterWater IntoxicationWater consumptionXerostomiaaging populationanimal tissuebasebiceps brachii muscleclinical research sitedesignfeedinghigh riskhuman studylight weightmalemental statemonitoring devicemortalityolder patientphase 1 studyphase 2 studypreventprototypepublic health relevancesoft tissuetissue phantomtoolyoung adult
项目摘要
DESCRIPTION (provided by applicant): Dehydration is a frequent cause of morbidity and mortality in the elderly. Identifying at risk individuals and maintaining adequate fluid balance is
an essential component of health care in aging population. Currently, there is no effective tool available to measure hydration status and distinguish those at risk. The reliability and validity o current hydration assessment methods and criteria such as thirst, skin turgor, blood pressure, pulse, urine output and specific gravity, MRI, dilution methods and bioimpedance, are limited; the methods are inaccurate or expensive. Given that dehydration is both preventable and reversible, the need for an easy-to-perform method for the detection of water imbalance is of the utmost clinical importance. The goal of this project is to develop and commercialize an inexpensive and easy-to-use device that monitors changes in hydration status and predicts at risk in home-bound and institutionalized elderly. The Hydration Monitor (HM) which is being developed under this grant can objectively quantify changes in the body water content and hydration status. The proprietary patented method implemented in the device is based on the experimental fact that ultrasound velocity through soft tissue is a linear function of the tissue water content. Because muscle provides the largest body reservoir for water, the assessment of water imbalance is conducted by measuring speed of ultrasound in muscle. In the course of Phase I studies we designed and assembled HM ¿-prototype, extensively tested it on tissue phantoms and excised animal tissues. Based on the results of these tests we designed the HM ¿-prototype for Phase II clinical studies. The aims of this Phase II SBIR project include building and bench-testing eight HM ¿-prototypes and providing the prototypes to three sites for clinical validation. The objectives of human studies include: to determine normal daily variation of the individual hydration level in longitudinal study on elderly in assisted living facility; to assess range between individual hydration baselines for elderly in a normal physiologically hydrated state; to establish the ability of the HM to assess initial and corrected hydration status in a population of elderly patients admitted to the hospital for hypernatremic dehydration; to determine euhydration and dehydration thresholds when employing ultrasound velocity measures in parallel with conventional tests and to detect changes in the hydration status of young healthy adults before and after undergoing 3% acute dehydration; and to test the hypothesis that body dehydration is a generalized physiological process equally affected all body muscles by comparing the data obtained on calf and biceps muscles. The Phase II activities will culminate with developing a pre-production HM prototype and preparing comprehensive engineering documentation. The device will aim to comply with respective FDA Quality System Regulations, Good Manufacturing Practices and regulations which are incorporated into Artann Laboratories quality systems.
描述(由适用提供):脱水通常是古老的发病率和死亡率的原因。确定处于风险的人并维持足够的流体平衡是
老龄化人口中医疗保健的重要组成部分。当前,尚无有效的工具来衡量水合状态并区分有风险的水平。可靠性和有效性o当前的水合评估方法和标准,例如第三,皮肤繁琐,血压,脉搏,尿液输出和比重,MRI,稀释方法和生物阻抗受到限制;这些方法不准确或昂贵。鉴于脱水既可以预防又可逆,因此需要一种易于表现的方法来检测水不平衡是至关重要的。该项目的目的是开发和商业化廉价且易于使用的设备,该设备可以监视水合状态的变化和预测在家庭界和机构化的风险上。在此赠款下开发的水合监视器(HM)可以客观地量化身体水含量和水合状态的变化。该设备中实施的专有专利方法是基于一个实验事实,即通过软组织进行超声速度是组织水含量的线性函数。由于肌肉为水提供了最大的身体晶状体,因此通过测量肌肉超声速度来进行水不平衡评估。在第一阶段研究的过程中,我们设计并组装了HM - prototype,在组织幻像和优秀的动物组织上进行了广泛的测试。基于这些测试的结果,我们为II期临床研究设计了HM—培训。该II阶段SBIR项目的目的包括建造和板凳测试八个HM` - 原型,并将原型提供给三个地点以进行临床验证。人类研究的目标包括:确定对辅助生活设施的纵向研究中单个水合水平的正常每日变化;评估在正常物理水合状态下基本水平基线之间的范围;建立HM评估入院高嗜热脱水的基本患者人群中最初和校正水合状态的能力;在与常规测试并行采用超声速度度量时,确定肠道和脱水阈值,并在接受3%急性脱水之前和之后检测年轻健康成年人水合状态的变化;并测试人体脱水是一种普遍的物理过程的假设,通过比较在小腿和二头肌肌肉上获得的数据,同样影响了所有身体肌肉。 II期活动将最终开发前制作的HM原型并准备全面的工程文档。该设备将旨在遵守相对的FDA质量系统法规,良好的制造实践和法规,这些法规纳入了Artann Laboratories质量系统。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Armen Sarvazyan其他文献
Armen Sarvazyan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Armen Sarvazyan', 18)}}的其他基金
Muscle viscosity as a protective mechanism for absorbing mechanical shock
肌肉粘度作为吸收机械冲击的保护机制
- 批准号:
8569231 - 财政年份:2013
- 资助金额:
$ 52.64万 - 项目类别:
Muscle viscosity as a protective mechanism for absorbing mechanical shock
肌肉粘度作为吸收机械冲击的保护机制
- 批准号:
8734322 - 财政年份:2013
- 资助金额:
$ 52.64万 - 项目类别:
Portable device for monitoring water balance in elderly
便携式老年人水平衡监测装置
- 批准号:
8704442 - 财政年份:2013
- 资助金额:
$ 52.64万 - 项目类别:
Portable device for monitoring water balance in elderly
便携式老年人水平衡监测装置
- 批准号:
8371203 - 财政年份:2012
- 资助金额:
$ 52.64万 - 项目类别:
Portable Ultrasonometer for Osteoporosis Assessment
用于骨质疏松症评估的便携式超声波仪
- 批准号:
7913453 - 财政年份:2009
- 资助金额:
$ 52.64万 - 项目类别:
Portable Imaging Device for Prostate Cancer Detection
用于前列腺癌检测的便携式成像设备
- 批准号:
7940196 - 财政年份:2009
- 资助金额:
$ 52.64万 - 项目类别:
Diagnostic Technology Based on Acoustic Radiation Force
基于声辐射力的诊断技术
- 批准号:
6598974 - 财政年份:2003
- 资助金额:
$ 52.64万 - 项目类别:
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
The Role of Outpatient Diuretic Therapy in Bronchopulmonary Dysplasia
门诊利尿疗法在支气管肺发育不良中的作用
- 批准号:
10663469 - 财政年份:2023
- 资助金额:
$ 52.64万 - 项目类别:
Integrated, Individualized, and Intelligent Prescribing (I3P) Clinical Trial Network
一体化、个体化、智能处方(I3P)临床试验网络
- 批准号:
10822651 - 财政年份:2023
- 资助金额:
$ 52.64万 - 项目类别:
Selective actin remodeling of sensory neurons for acute pain management
感觉神经元的选择性肌动蛋白重塑用于急性疼痛管理
- 批准号:
10603436 - 财政年份:2023
- 资助金额:
$ 52.64万 - 项目类别:
Traumatic Brain Injury Anti-Seizure Prophylaxis in the Medicare Program
医疗保险计划中的创伤性脑损伤抗癫痫预防
- 批准号:
10715238 - 财政年份:2023
- 资助金额:
$ 52.64万 - 项目类别:
Targeting Alcohol-Opioid Co-Use Among Young Adults Using a Novel MHealth Intervention
使用新型 MHealth 干预措施针对年轻人中酒精与阿片类药物的同时使用
- 批准号:
10456380 - 财政年份:2023
- 资助金额:
$ 52.64万 - 项目类别: